ABSOLUTE PRO .035 SELF EXPANDING STENT SYSTEM
Report
- Report Number
- 2024168-2013-03035
- Event Type
- Injury
- Date Received
- May 14, 2013
- Date of Event
- July 1, 2010
- Report Date
- April 8, 2013
- Manufacturer
- AV-TEMECULA-CT
- Product Code
- FGE
- PMA / PMN Number
- K072708
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- BE
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
(B)(4). DATE OF EVENT ESTIMATED AS ONE YEAR FROM START OF STUDY. THERE WAS NO REPORTED PRODUCT DEFICIENCY. THE REPORTED PATIENT EFFECT OF RESTENOSIS IS A KNOWN OBSERVED AND POTENTIAL ADVERSE EVENT AS LISTED IN THE ABSOLUTE PRO .035 PERIPHERAL SELF EXPANDING STENT SYSTEM INSTRUCTIONS FOR USE. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECTS, AND THE RELATIONSHIP TO THE PRODUCT, IF ANY, CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURING, DESIGN OR LABELING. THE OMNILINK ELITE REFERENCED IS BEING FILED UNDER A SEPARATE MEDWATCH REPORT.
THIS EVENT WAS CAPTURED BASED ON LITERATURE REVIEW. IT WAS REPORTED THAT A PROSPECTIVE, NON-RANDOMIZED, MULTI-CENTER, MULTI-NATIONAL, MONITORED TRIAL CONDUCTED AT 12 HOSPITALS IN (B)(6) AND 11 HOSPITALS IN (B)(6), IDENTIFIED A TOTAL OF 325 PATIENTS WHO RECEIVED UNKNOWN ABSOLUTE PRO STENTS AND UNKNOWN OMNILINK ELITE STENTS IMPLANTED IN TRANS-ATLANTIC INTER-SOCIETY CONSENSUS (TASC) A/B AND TASC C/D ILIAC LESIONS BETWEEN JULY 2009 AND SEPTEMBER 2010. THE 12-MONTH PRIMARY PATENCY RATE WAS 92% IN LESIONS TREATED WITH THE OMNILINK ELITE STENTS AND 96% IN LESIONS TREATED WITH THE ABSOLUTE PRO STENTS. NO ADDITIONAL INFORMATION WAS PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 212322 | ABSOLUTE PRO .035 SELF EXPANDING STENT SYSTEM | SELF EXPANDING STENT SYSTEM | FGE | AV-TEMECULA-CT |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Other |